These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6751064)

  • 1. Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil.
    Singh BN; Chew CY; Josephson MA; Packer M
    Am J Cardiol; 1982 Oct; 50(4):886-93. PubMed ID: 6751064
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic and clinical effects of combined verapamil and propranolol therapy in angina pectoris.
    Packer M; Leon MB; Bonow RO; Kieval J; Rosing DR; Subramanian VB
    Am J Cardiol; 1982 Oct; 50(4):903-12. PubMed ID: 6751066
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of verapamil on coronary hemodynamics in patients with coronary heart disease.
    Simonsen S
    Eur J Cardiol; 1978 Aug; 8(1):9-18. PubMed ID: 689073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease.
    Brogden RN; Benfield P
    Drugs; 1996 May; 51(5):792-819. PubMed ID: 8861548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic basis of antianginal effect of calcium antagonists in patients with ischemic heart disease after aortocoronary shunting: myocardial reserve potentials and their mechanisms].
    Knyshov GV; Vykhovaniuk IV; Tkhor NV; Furkalo SN; Korchinskaia OI
    Kardiologiia; 1993; 33(12):64-9. PubMed ID: 8196260
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute haemodynamic effects of cromakalim in patients with angina pectoris.
    Thomas P; Dixon MS; Winterton SJ; Sheridan DJ
    Br J Clin Pharmacol; 1990 Mar; 29(3):325-31. PubMed ID: 2310656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianginal drugs for stable angina pectoris.
    Aronow WS
    Ration Drug Ther; 1982 Jan; 16(1):1-7. PubMed ID: 6799985
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronary vasoconstriction: where do we stand in 1999. An important, multifaceted but elusive role.
    Maseri A; Crea F; Lanza GA
    Cardiologia; 1999 Feb; 44(2):115-8. PubMed ID: 10208047
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiocirculatory and antianginal actions of nitroglycerin ointment. Evaluation by cardiac catheterization, forearm plethysmography and treadmill stress testing.
    Awan NA; Miller RR; Maxwell KS; Mason DT
    Chest; 1978 Jan; 73(1):14-8. PubMed ID: 413695
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of intravenous verapamil on the haemodynamic response to exercise in patients with angina pectoris.
    Sadick N; Roubin GS; Harris PJ; Hiroe M; Meares S; Bautovich G; Kelly DT
    Acta Med Scand Suppl; 1984; 681():91-8. PubMed ID: 6587758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenously administered verapamil on hemodynamic variables and ventricular function in acute myocardial infarction.
    Singh BN; Chew CY; Hecht H; Collett J; Ormiston J
    Clin Invest Med; 1980; 3(1-2):73-80. PubMed ID: 7471543
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of verapamil on regional myocardial contraction during graded ischemia in the dog.
    Romson JL; Buffington CW; Williams DB; Itoh T; Thomas R; Breazeale DG; Ivey TD
    J Cardiovasc Pharmacol; 1986; 8(1):71-6. PubMed ID: 2419697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential selection of anti-anginal drugs in stable stenocardia in relation to the data of central and intracardiac hemodynamics].
    Manak NA; Laziuk DG; Karoza AE; Karpova IS; Prokopchuk VP
    Kardiologiia; 1992 Jan; 32(1):44-7. PubMed ID: 1614020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in infarct size following experimental coronary occlusion by administration of verapamil.
    Singh BN; Smith HJ; Norris RM
    Recent Adv Stud Cardiac Struct Metab; 1975; 10():435-52. PubMed ID: 813284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of isoptin and obsidan on the coronary blood flow and tactics in anti-angina therapy of patients with ischemic heart disease].
    Vakhliev VD; Bogatyrev IV; Uchaĭkina LV; Syrkin AL
    Kardiologiia; 1988 Oct; 28(10):36-9. PubMed ID: 3066966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianginal drugs.
    Kaverina NV; Chumburidze VB
    Pharmacol Ther; 1979; 4(1):109-53. PubMed ID: 88742
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute hemodynamic effects of intravenous tiapamil in patients with coronary artery disease.
    Bopp P; Mérier G; Scheidegger D; Gabathuler J; Rutishauser W
    Cardiology; 1982; 69 Suppl():91-8. PubMed ID: 7151088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic mechanisms of the antianginal action of a novel vasodilator FK409 in dynamic exercise-induced angina.
    Yokota M; Matsunami T; Kodama Y; Sobue T; Nishinaka Y; Iwase M; Miyahara T; Koide M; Saito H; Shibata S
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):412-22. PubMed ID: 7681502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetodardiographic approach to the evaluation of antianginal drugs.
    Slany J; Mösslacher H; Kronik G
    Bibl Cardiol; 1976; (35):191-6. PubMed ID: 825098
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of high dose aspirin on coronary hemodynamics during pacing-induced myocardial ischemia.
    Martin JL; Fisher CA; Untereker WJ; Laskey WK; Hirshfeld JW; Harken AH; Addonizio VP
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):210-5. PubMed ID: 3968305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.